# Aardvark Therapeutics, Inc.: Form 8-K, filed Feb 10, 2026

- Company: [Aardvark Therapeutics, Inc.](/companies/aard.md) (CIK 1774857)
- Form: 8-K
- Filed: 2026-02-10
- Accepted by EDGAR: Feb 10, 2026, 08:14 ET
- Period: 2026-02-10
- Accession: 0001193125-26-043764
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1774857/000119312526043764/ck0001774857-20260210.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1774857/000119312526043764/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1774857/000119312526043764/ck0001774857-20260210.htm

Filed Feb 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-043764. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
